CMRX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 13.10%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $92,241.70

Chimerix Insider Trading History Chart

Chimerix Share Price & Price History

^$8.54

+0.30 (1.20%)

As of 04/21/2025 01:00 AM ET

Days: 30 | 90 | 365

Chimerix Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/13/2025	Allen S. Melemed	Insider	Sell	3,065	$4.50	$13,792.50	152,875
2/13/2025	David Jakeman	VP	Sell	300	$4.53	$1,359.00	148,987
2/13/2025	Michael Albert Alrutz	SVP	Sell	1,600	$4.52	$7,232.00	213,596
2/13/2025	Michael T. Andriole	CEO	Sell	7,370	$4.52	$33,312.40	609,603
2/13/2025	Michelle LaSpaluto	CFO	Sell	2,260	$4.51	$10,192.60	172,977
1/30/2025	David Jakeman	VP	Sell	2,800	$4.10	$11,480.00	149,287
1/30/2025	Michael T. Andriole	CEO	Sell	2,350	$4.10	$9,635.00	616,973
1/30/2025	Michelle LaSpaluto	CFO	Sell	1,015	$4.11	$4,171.65	175,237
8/8/2024	Michael T. Andriole	CEO	Sell	1,285	$0.83	$1,066.55	462,453
2/14/2024	David Jakeman	VP	Sell	2,660	$1.04	$2,766.40	141,232
2/14/2024	Michael T. Andriole	CEO	Sell	1,744	$1.04	$1,813.76	447,021
2/14/2024	Michelle LaSpaluto	CFO	Sell	1,940	$1.04	$2,017.60	110,999
11/10/2023	Fred A. Middleton	Director	Buy	2,705	$0.92	$2,488.60	82,705
9/28/2023	David Jakeman	VP	Sell	3,610	$0.99	$3,573.90	133,142
9/25/2023	Fred A. Middleton	Director	Buy	20,000	$0.98	$19,600.00	80,000
5/18/2023	Michael T. Andriole	CFO	Buy	51,700	$1.14	$58,938.00	357,015
5/10/2023	Martha J. Demski	Director	Buy	18,000	$1.11	$19,980.00	72,055
5/8/2023	Robert J. Meyer	Director	Buy	8,750	$1.14	$9,975.00	35,150
3/28/2023	Fred A. Middleton	Director	Buy	20,000	$1.21	$24,200.00	60,000
1/26/2023	David Jakeman	Insider	Sell	3,230	$1.76	$5,684.80	136,752
9/29/2022	David Jakeman	Insider	Sell	4,400	$1.86	$8,184.00	127,532
9/29/2022	Fred A. Middleton	Director	Buy	20,000	$1.86	$37,200.00	40,000
5/19/2022	Robert J. Meyer	Director	Buy	11,400	$2.06	$23,484.00	26,400
5/17/2022	Martha J. Demski	Director	Buy	10,000	$1.61	$16,100.00	54,055
5/17/2022	Michael T. Andriole	CFO	Buy	15,000	$1.71	$25,650.00	212,724

See Full Table

SEC Filings (Institutional Ownership Changes) for Chimerix (NASDAQ:CMRX)

45.42% of Chimerix stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Chimerix Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
4/28/2025	CIBRA Capital Ltd	731,699	$6.23M	2.1%	N/A	0.780%
4/25/2025	Koshinski Asset Management Inc.	50,000	$0.43M	0.0%	+35.1%	0.053%
4/22/2025	Palumbo Wealth Management LLC	58,954	$0.50M	0.2%	-7.0%	0.063%
2/17/2025	Squarepoint Ops LLC	37,297	$0.13M	0.0%	N/A	0.041%
2/17/2025	Two Sigma Advisers LP	11,900	$41K	0.0%	-63.4%	0.013%
2/17/2025	Two Sigma Investments LP	101,156	$0.35M	0.0%	+309.1%	0.112%
2/17/2025	Shay Capital LLC	65,220	$0.23M	0.0%	-71.6%	0.073%
2/17/2025	OMERS ADMINISTRATION Corp	153,800	$0.54M	0.0%	N/A	0.171%
2/17/2025	Millennium Management LLC	2,557,530	$8.90M	0.0%	+6.8%	2.844%
2/17/2025	Deerfield Management Company L.P. Series C	3,771,342	$13.12M	0.2%	N/A	4.193%
2/17/2025	Balyasny Asset Management L.P.	60,317	$0.21M	0.0%	N/A	0.067%
2/14/2025	Boxer Capital Management LLC	2,060,000	$7.17M	0.6%	N/A	2.290%
2/14/2025	Jane Street Group LLC	17,872	$62K	0.0%	N/A	0.020%
2/14/2025	Northern Trust Corp	549,841	$1.91M	0.0%	-6.2%	0.611%
2/14/2025	Susquehanna Fundamental Investments LLC	16,859	$59K	0.0%	N/A	0.019%
2/14/2025	Diadema Partners LP	29,082	$0.10M	0.0%	N/A	0.032%
2/13/2025	Marshall Wace LLP	2,213,940	$7.71M	0.0%	+1,318.5%	2.462%
2/13/2025	EAM Investors LLC	225,777	$0.79M	0.1%	N/A	0.251%
2/13/2025	Walleye Capital LLC	391,274	$1.36M	0.0%	N/A	0.435%
2/13/2025	Renaissance Technologies LLC	820,349	$2.86M	0.0%	-38.7%	0.912%
2/13/2025	ADAR1 Capital Management LLC	122,236	$0.43M	0.1%	-49.2%	0.136%
2/13/2025	Yakira Capital Management Inc.	103,489	$0.36M	0.1%	-79.6%	0.115%
2/12/2025	Geode Capital Management LLC	836,696	$2.91M	0.0%	-1.1%	0.930%
2/11/2025	Rosalind Advisors Inc.	3,050,000	$10.61M	5.3%	N/A	3.391%
2/10/2025	Monaco Asset Management SAM	2,820,792	$9.82M	1.4%	-33.2%	3.136%
2/10/2025	Connor Clark & Lunn Investment Management Ltd.	429,513	$1.50M	0.0%	+24.6%	0.478%
2/7/2025	Bender Robert & Associates	10,609	$37K	0.0%	N/A	0.012%
2/6/2025	Charles Schwab Investment Management Inc.	52,657	$0.18M	0.0%	N/A	0.059%
1/30/2025	Palumbo Wealth Management LLC	63,400	$0.22M	0.1%	N/A	0.070%
1/30/2025	Valeo Financial Advisors LLC	146,186	$0.51M	0.0%	+78.8%	0.163%
1/30/2025	Vontobel Holding Ltd.	40,000	$0.14M	0.0%	-42.9%	0.044%
1/29/2025	Peapod Lane Capital LLC	754,566	$2.63M	2.6%	N/A	0.839%
1/28/2025	Stoneridge Investment Partners LLC	44,305	$0.15M	0.1%	+22.5%	0.049%
1/14/2025	Marquette Asset Management LLC	108,986	$0.38M	0.1%	-6.1%	0.121%
1/14/2025	Assenagon Asset Management S.A.	817,739	$2.85M	0.0%	+154.8%	0.909%
11/16/2024	Geode Capital Management LLC	846,249	$0.79M	0.0%	-4.5%	0.941%
11/8/2024	Connor Clark & Lunn Investment Management Ltd.	344,712	$0.32M	0.0%	+66.8%	0.385%
10/23/2024	Assenagon Asset Management S.A.	320,916	$0.30M	0.0%	-20.7%	0.358%
10/10/2024	Valeo Financial Advisors LLC	81,766	$76K	0.0%	+566.9%	0.091%
8/15/2024	Armistice Capital LLC	2,224,000	$1.95M	0.0%	-1.8%	2.481%
8/14/2024	Marshall Wace LLP	156,076	$0.14M	0.0%	N/A	0.174%
8/9/2024	Renaissance Technologies LLC	1,483,178	$1.30M	0.0%	-20.0%	1.655%
7/18/2024	Assenagon Asset Management S.A.	404,709	$0.36M	0.0%	-10.9%	0.452%
5/10/2024	Acadian Asset Management LLC	2,174,813	$2.30M	0.0%	+15.5%	2.426%
5/9/2024	Koshinski Asset Management Inc.	40,000	$42K	0.0%	N/A	0.045%
5/7/2024	Marquette Asset Management LLC	116,009	$0.12M	0.0%	+24.3%	0.129%
4/24/2024	Assenagon Asset Management S.A.	454,468	$0.48M	0.0%	-9.0%	0.509%
2/14/2024	Pale Fire Capital SE	211,214	$0.20M	0.0%	+113.6%	0.238%
2/14/2024	Vestal Point Capital LP	1,400,000	$1.35M	0.1%	N/A	1.575%
2/13/2024	Armistice Capital LLC	2,598,000	$2.50M	0.0%	-9.5%	2.923%
2/5/2024	Vance Wealth Inc.	47,320	$46K	0.0%	N/A	0.053%
2/2/2024	Acuitas Investments LLC	316,581	$0.30M	0.2%	-30.8%	0.356%
1/17/2024	Assenagon Asset Management S.A.	499,391	$0.48M	0.0%	+17.0%	0.562%
11/15/2023	RA Capital Management L.P.	6,501,624	$6.24M	0.1%	N/A	7.314%
11/15/2023	Armistice Capital LLC	2,872,000	$2.76M	0.0%	-9.6%	3.231%
11/14/2023	Pale Fire Capital SE	98,896	$95K	0.0%	N/A	0.111%
11/6/2023	Assenagon Asset Management S.A.	426,672	$0.41M	0.0%	+167.3%	0.482%
10/24/2023	Bank of New York Mellon Corp	591,697	$0.57M	0.0%	+190.0%	0.668%
10/11/2023	Vontobel Holding Ltd.	70,000	$67K	0.0%	+40.0%	0.079%
9/21/2023	Barclays PLC	834,544	$1.01M	0.0%	-4.9%	0.942%
8/14/2023	Shay Capital LLC	83,385	$0.10M	0.0%	N/A	0.094%
8/14/2023	Graham Capital Management L.P.	24,756	$30K	0.0%	N/A	0.028%
8/11/2023	Tejara Capital Ltd	372,640	$0.45M	0.2%	-5.0%	0.421%
8/9/2023	BNP Paribas Arbitrage SNC	538,215	$0.65M	0.0%	+517.1%	0.608%
8/8/2023	Monaco Asset Management SAM	4,377,674	$5.30M	1.5%	+83.5%	4.942%
8/7/2023	Acadian Asset Management LLC	2,041,883	$2.47M	0.0%	+2.6%	2.305%
8/3/2023	Barclays PLC	834,544	$1.01M	0.0%	-4.9%	0.942%
7/31/2023	PVG Asset Management Corp	28,655	$35K	0.2%	-58.8%	0.032%
7/28/2023	Marquette Asset Management LLC	94,582	$0.11M	0.0%	N/A	0.107%
7/25/2023	Assenagon Asset Management S.A.	159,628	$0.19M	0.0%	-41.7%	0.180%
7/24/2023	Vontobel Holding Ltd.	50,000	$60K	0.0%	-52.4%	0.056%
5/15/2023	Rubric Capital Management LP	7,336,735	$9.24M	0.2%	-2.2%	8.282%
5/12/2023	Yakira Capital Management Inc.	508,389	$0.64M	0.2%	N/A	0.574%
5/12/2023	Tejara Capital Ltd	392,359	$0.49M	0.3%	+20.0%	0.443%
5/11/2023	Acadian Asset Management LLC	1,989,699	$2.51M	0.0%	+90.9%	2.246%
5/10/2023	Connor Clark & Lunn Investment Management Ltd.	221,039	$0.28M	0.0%	-15.8%	0.250%
5/8/2023	Bailard Inc.	33,600	$42K	0.0%	N/A	0.038%
5/4/2023	Barclays PLC	877,233	$1.11M	0.0%	+29.4%	0.994%
4/28/2023	SG Americas Securities LLC	33,785	$43K	0.0%	+139.3%	0.038%
4/18/2023	Assenagon Asset Management S.A.	273,745	$0.35M	0.0%	+3.7%	0.310%
4/14/2023	Raymond James & Associates	64,200	$81K	0.0%	+39.4%	0.073%
4/13/2023	Allspring Global Investments Holdings LLC	128,976	$0.16M	0.0%	-65.6%	0.146%
3/23/2023	MetLife Investment Management LLC	44,657	$83K	0.0%	N/A	0.051%
2/13/2023	The Manufacturers Life Insurance Company	33,517	$62K	0.0%	+107.3%	0.038%
2/10/2023	Connor Clark & Lunn Investment Management Ltd.	262,404	$0.49M	0.0%	+522.0%	0.298%
2/8/2023	Russell Investments Group Ltd.	406,626	$0.76M	0.0%	+91.7%	0.462%
2/2/2023	SG Americas Securities LLC	14,121	$26K	0.0%	-39.1%	0.016%
2/2/2023	Mission Wealth Management LP	33,860	$63K	0.0%	N/A	0.038%
1/31/2023	Monaco Asset Management SAM	2,310,375	$4.30M	1.2%	+9.2%	2.624%
1/26/2023	Strs Ohio	81,000	$0.15M	0.0%	+78.4%	0.092%
1/23/2023	Allspring Global Investments Holdings LLC	374,882	$0.70M	0.0%	+5.1%	0.426%
1/20/2023	Clear Harbor Asset Management LLC	22,500	$42K	0.0%	-39.2%	0.026%
1/12/2023	Assenagon Asset Management S.A.	264,059	$0.49M	0.0%	-8.1%	0.300%
12/9/2022	Penn Capital Management Company LLC	23,802	$46K	0.0%	-97.2%	0.027%
11/17/2022	Telemetry Investments L.L.C.	50,000	$96K	0.1%	N/A	0.057%
11/15/2022	Bayesian Capital Management LP	58,936	$0.11M	0.0%	N/A	0.067%
11/15/2022	Caxton Associates LP	158,670	$0.31M	0.0%	+169.4%	0.180%
11/14/2022	Zacks Investment Management	14,394	$28K	0.0%	N/A	0.016%
11/14/2022	Armistice Capital LLC	2,756,000	$5.32M	0.1%	-21.8%	3.130%
11/14/2022	Rubric Capital Management LP	6,625,000	$12.79M	0.6%	-6.5%	7.525%

Data available starting January 2016

See Full Table

Chimerix, Inc., a biopharmaceutical company, develops medicines to improve and extend the lives of patients facing deadly diseases. Its pipeline products include ONC201 a program that is in Phase 3 clinical trial for treating patients with H3 K27M-mutant diffuse glioma, as well as in Phase 2 clinical trial for the treatment of rare neuroendocrine tumors; and ONC206, an imipridone, Dopamine Receptor D2 (DRD2) antagonist, and caseinolytic protease P (ClpP) agonist, which is in Phase 1 clinical trial for adult and pediatric patients with primary central nervous system tumors. The company also develops ONC212, an imipridone agonist of the orphan G protein-coupled receptors (GPCR) tumor suppressor GPR132, as well as ClpP for oncology indications; and CMX521, a nucleoside analog antiviral drug candidate for the treatment of SARS-CoV-2. It has license agreement with SymBio Pharmaceuticals to develop and commercialize TEMBEXA for human diseases other than orthopoxviruses, including smallpox. Chimerix, Inc. was incorporated in 2000 and is headquartered in Durham, North Carolina.

Today's Range

Now: $8.54

$8.54

50 Day Range

MA: $7.86

$4.60

$8.55

52 Week Range

Now: $8.54

$0.75

$8.55

Volume

N/A

Average Volume

2,283,901 shs

Market Capitalization

$801.09 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Chimerix?: Chimerix's top insider investors include:
Michael T Andriole (CEO)
Michael T Andriole (CFO)
Michael Albert Alrutz (SVP)
Michelle Laspaluto (CFO)
Allen S Melemed (Insider)
David Jakeman (VP)
Fred A Middleton (Director)
Martha J Demski (Director)
Robert J Meyer (Director)
Learn More about top insider investors at Chimerix.
Who are the major institutional investors of Chimerix?: Chimerix's top institutional investors include:
CIBRA Capital Ltd — 0.78%
Palumbo Wealth Management LLC — 0.06%
Koshinski Asset Management Inc. — 0.05%
Learn More about top institutional investors of Chimerix stock.
Which institutional investors are selling Chimerix stock?: In the previous quarter, CMRX stock was sold by these institutional investors:
Palumbo Wealth Management LLC
During the previous year, company insiders that have sold Chimerix company stock include:
Michael T Andriole (CEO)
Michael T Andriole (CFO)
Michael Albert Alrutz (SVP)
Michelle Laspaluto (CFO)
Allen S Melemed (Insider)
Learn More investors selling Chimerix stock.
Which institutional investors are buying Chimerix stock?: Within the last quarter, CMRX stock was bought by institutional investors including:
CIBRA Capital Ltd
Koshinski Asset Management Inc.
Within the previous year, these company insiders have bought Chimerix stock:
Michael T Andriole (CEO)
Michael T Andriole (CFO)
Michael Albert Alrutz (SVP)
Michelle Laspaluto (CFO)
Learn More investors buying Chimerix stock.